|Other names||CP-10188; Fenclonina; Fencloninum; NSC-77370; Parachlorophenylalanine|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||199.634 g/mol g·mol−1|
|3D model (JSmol)|
|Melting point||240 °C (464 °F)|
|Boiling point||339.5 °C (643.1 °F)|
Fenclonine, also known as para-chlorophenylalanine (PCPA), acts as a selective and irreversible inhibitor of tryptophan hydroxylase, which is a rate-limiting enzyme in the biosynthesis of serotonin.
The effects of serotonin depletion from fenclonine are so drastic that serotonin cannot even be detected immunohistochemically within the first day after administration of a control dose. Tryptophan hydroxylase activity can be detected neither in cell bodies or nerve terminals. After one week 10% of control values (the baseline extrapolated for the study) had replenished in the raphe nucleus, and after two weeks from initial treatment as much was again detected in the hypothalamus region. Aromatic L-amino acid decarboxylase (AADC) levels were at no time affected.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|